Table 2.
Laboratory investigations of the patient during the hospital stay.
| LABORATORY INVESTIGATIONS | DAY 1 | DAY 2 | DAY 3 |
STEROID THERAPY STARTED |
DAY 5 | DAY 8 | DAY 13 | DAY 16 | NORMAL RANGE |
| Complete blood count | |||||||||
| Haemoglobin | 11.0 | 9.4 | 8.9 | 8.1 | 6.0 | 7.2 | 8.3 | 12.0–15.0gm/dl | |
| RBC | 3.7 | 3.3 | 3.1 | 2.8 | 2.2 | 2.7 | 3.1 | 4.5–5.5 million/mm3 | |
| PCV | 30 | 27 | 26 | 23 | 18 | 22 | 25 | 40–50% | |
| RDW | 13 | 13 | 14 | 14 | 15 | 15 | 15 | 11.6–14% | |
| Neutrophils (%) | 64 | 61 | 60 | 40 | 50 | 69 | 76 | 40–80% | |
| Lymphocytes (%) | 11 | 18 | 31 | 45 | 25 | 28 | 20 | 20–40% | |
| Eosinophils (%) | 21 | 18 | 02 | 05 | 15 | 01 | 02 | 1–6% | |
| Monocytes (%) | 4 | 0.3 | 7 | 10 | 10 | 02 | 02 | 2–10% | |
| Basophils (%) | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 0–2% | |
| Absolute neutrophils count | 7732 | 6527 | 5520 | 28880 | 2900 | 4692 | 7296 | 2000–7000 cells/mm3 | |
| Absolute lymphocyte count | 1243 | 1926 | 2852 | 3240 | 1450 | 1904 | 1920 | 1000–3000 cells/mm3 | |
| Absolute eosinophil count | 2373 | 1926 | 184 | 360 | 870 | 68 | 192 | 20–500 cells/mm3 | |
| Absolute monocyte count | 452 | 321 | 644 | 720 | 580 | 136 | 0 | 200–1000 cells/mm3 | |
| Platelet count (x103) | 232 | 219 | 159 | 1500 | 150 | 254 | 300 | 150000–410000/mm3 | |
| Total WBC | 11300 | 10700 | 9200 | 7200 | 5800 | 6800 | 9600 | 4000–10000clls/mm3 | |
| LFT | |||||||||
| Total bilirubin | 8.9 | 9.8 | 10.2 | 10.2 | 12.7 | 9.1 | 0.3–1.2 mg/dL | ||
| Direct Bilirubin/Indirect Bilirubin | 5.4/3.5 | 6.7/3.7 | 6.3/3.9 | 6.3/3.9 | 7.5/5.2 | 5.1/4.0 | 0–0.2mg/dl 0.2–0.8 mg/dL |
||
| SGPT (ALT)/SGOT (AST) | 386/583 | 553/993 | 450/650 | 307/281 | 295/294 | 212/162 | Upto 40 U/L/0–35 U/L | ||
| ALP | 176 | 152 | 155 | 200 | 394 | 397 | 30–120U/L | ||
| Total proteins | 5.5 | 4.8 | 5.0 | 5.4 | 5.3 | 5.5 | 6.6–8.3g/dl | ||
| Albumin | 2.9 | 2.3 | 2.4 | 2.5 | 2.8 | 3.0 | 3.5–5.1g/dl | ||
| C-reactive protein | 76.1 | 188 | 29 | <10mg/dl | |||||
| Ferritin | 22550 | 2070 | 13–150ng/ml | ||||||